Abbott's robust sales of medical devices fuel positive quarter as surgery rises Kajal Rajput21 July 2023 2:53 PM ISTNew Delhi: Abbott Laboratories on Thursday beat quarterly profit expectations as a rebound in surgical procedure volumes drove demand for medical...
Baby powder suit: Johnson and Johnson must pay USD 18.8 million to California cancer patient Ruchika Sharma19 July 2023 3:57 PM ISTJohnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided...
JnJ sues in latest bid to halt Medicare drug price negotiations Ruchika Sharma19 July 2023 3:41 PM ISTJohnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government...
Phase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen Ruchika Sharma18 July 2023 1:30 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 PAPILLON study ...
JnJ sues researchers who linked talc to cancer Ruchika Sharma14 July 2023 3:00 PM ISTNew Jersey: Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer,...
Jurors urged to impose heavy punitive damages in JnJ talc trial Ruchika Sharma12 July 2023 4:30 PM ISTLawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on...
Bausch + Lomb acquires JnJ eye, contact lens drops brand Blink for USD 106.5 million Ruchika Sharma7 July 2023 3:10 PM ISTBausch + Lomb acquired Johnson & Johnson's eye and contact lens drops brand Blink for $106.5 million, marking its second deal in two weeks to...
Janssen reports positive results from phase 2b FRONTIER 1 trial of JNJ-2113 in plaque psoriasis patients Ruchika Sharma6 July 2023 2:30 PM ISTJNJ-2113 is a novel oral IL-23R antagonist peptide that binds with high affinity to the IL-23R and has properties that allow it to be absorbed with...
Cancer plaintiffs drill down on JnJ support for USD 8.9 billion talc deal Ruchika Sharma29 Jun 2023 2:30 PM ISTNew York: The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in...
California man tells jury of getting cancer after using JnJ baby powder Ruchika Sharma27 Jun 2023 3:30 PM ISTA California man suing Johnson & Johnson told jurors on Monday how his life was upended by a cancer diagnosis that he blames on using the...
Janssen seeks USFDA nod for single tablet combination therapy of Macitentan, Tadalafil for Pulmonary Arterial Hypertension Ruchika Sharma31 May 2023 3:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a New Drug Application (NDA) to the U.S. Food...
Amgen settles patent lawsuit over biosimilar of JnJ's Stelara Ruchika Sharma25 May 2023 2:50 PM ISTStelara is a biologic drug, meaning it is derived from living cells and cannot be exactly duplicated.
